ArticleFrontiers in pharmacology2022

A real-world cost-effectiveness analysis of nebulized budesonide and intravenous methylprednisolone in acute exacerbation of chronic obstructive pulmonary disease.

Yong-Li Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.